• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ROIV

ROIV

Roivant Sciences Ltd.

NASDAQHealthcareBiotechnologyGB

USD28.70

+0.45 (+1.59%)

Rating:C

Company Profile

CEO

Matthew Gline

IPO Date

2020-12-08

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

GB

Market Metrics

Open

$28.29

Prev. Close

$28.25

Day Low

$28.18

Day High

$28.80

52W Low

$10.71

52W High

$32.79

Market Cap

$20.64B

Volume

3.41M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

14

Hold

1

Sell

0

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
26 May 2026GuggenheimBuyBuymaintain
21 May 2026HC Wainwright & Co.BuyBuymaintain
21 May 2026CitigroupBuyBuymaintain
21 May 2026
TD Cowen
Buy
Buy
maintain
16 Apr 2026Piper SandlerOverweightOverweightmaintain
4 Mar 2026HC Wainwright & Co.BuyBuymaintain
10 Feb 2026HC Wainwright & Co.BuyBuymaintain
10 Feb 2026CitigroupBuyBuymaintain
9 Feb 2026GuggenheimBuyBuymaintain
15 Dec 2025Leerink PartnersOutperformOutperformmaintain